1、Wang Liwei*,Keping Xie. Nitric Oxide and Pancreatic Cancer Pathogenesis, Prevention, and Treatment. Current Pharmaceutical Design,2010;4(16):421-427
2、Jia Z, Gao Y, Wang L（王理伟）, Li Q, Zhang J, Le X, Wei D, Yao JC, Chang DZ, Huang S, Xie K.. Combined treatment of pancreatic cancer with mithramycin A and tolfenamic acid promotes Sp1 degradation and synergistic antitumor activity. Cancer Res,2010;70(3):1111-1119
3、李宁,杨丽娟,周翡,李琦,高勇,王理伟#. 转录因子 Sp1 siRNA表达质粒的构建及对 Huh2 7肝癌细胞增殖的作用.. 肿瘤,2009;29(6):550-553
4、Liwei Wang, Xiaohong Guan, Jun Zhang Zhiliang Jia, Daoyan Wei, Qiang Li, James Yao and Keping Xie. Targeted inhibition of Sp1-mediated transcription for antiangiogenic therapy of metastatic human gastric cancer in orthotopic nude mouse models. International Journal of Oncology,2008;33(6):161-167
5、陈栋晖;宋卫峰;王理伟. 伊立替康二线治疗晚期结直肠癌疗效观察. 中国癌症杂志,2008;18(7):542-544
6、Yuan P, Wang L*,（王理伟）, Wei D, Zhang J, Jia Z, Li Q, Le X, Wang H, Yao J, Xie K.. Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer.. Cancer,2007;110(12):2682-2690
7、16.王理伟*,李琦,华召来,周翡,Keping Xie,Daoyan Wei,James Yao,Jaffer Ajani.. 转录因子Sp1与胃癌组织中的表达及其与胃癌预后的关系. 中华肿瘤杂志,2007;29(2):107-111.
8、Wang L（王理伟）,Guan X, Gong W, Yao J, Peng Z, Wei D, Wu TT, Huang S, Xie K. Altered Expression of Transcription Factor Sp1 Critically Impacts the Angiogenic Phenotype of Human Gastric Cancer.. Clin Exp Metastasis,2005;22（3）:205-213
|
